Please assess the completion status of the following clinical trial:

Trial Title: Neuroprotection With Minocycline Therapy for Acute Stroke Recovery Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Singapore citizens or permanent residents~* Age range between 21 to 80 years~* NIHSS equal or more than 5 but less than 22 at time of admission~* Clinical diagnosis of acute ischemic stroke according to WHO criteria~* Onset of stroke between 3 to 48 hours prior to start of treatment~* Must have a working telephone line~Exclusion Criteria:~* Long term residents of Institutions and Nursing homes~* Patients with significant baseline cognitive dysfunction~* Patients with hemorrhagic stroke~* Pre-stroke MRS more than 1~* Evidence of other disease of the CNS (i.e., brain tumor, CNS infections)~* Known allergic response to tetracycline~* Acute or Chronic renal failure~* Hepatitis or liver disease~* Pre-existing infectious disease requiring antibiotics~* Receipts of IV rTPA~* Participation in another clinical trial in the preceding 3 months~* Unable or unwilling to provide inform consent~* Unwilling to return for frequent clinic visits~* Geographic or social factors making the study participation impractical

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- matching placebo pill (Type: PLACEBO_COMPARATOR): matching placebo
- Oral minocycline (Type: ACTIVE_COMPARATOR): Minocycline 200mg

Based on this trial design, predict the completion outcome and termination type (if applicable).